Carole Ho
Carole Ho is Chief Medical Officer and Head of Development. At Denali, Carole has built an integrated Development organization that is responsible for advancing therapeutic candidates from pre-IND enabling studies through Phase 1 to Phase 3 clinical trials.
Contact
- Social accounts: linkedin
Companies
Company
Roles
Beam Therapeutics
A synthetic biology company using CRISPR to develop a portfolio of genetic medicines.
Board Member
NGM Biopharmaceuticals
A biopharmaceutical company developing therapeutics for the treatment of cardio-metabolic and liver diseases
Board Member